Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S H Bell

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Diabetologia|January 20, 2007
Comment on: Distiller LA, Joffe BI (2006) From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a 'routine' diabetes clinic? Diabetologia 49:2793-2794D S H Bell
Diabetologia|June 30, 2010
Nocturnal hypoglycaemia presenting as somnambulismD S H Bell
Diabetologia|April 17, 2010
Hyperglycaemia and ketosis induced by gamma hydroxybutyrate (GHB)D S H Bell
Diabetes, Obesity & Metabolism|September 28, 2012
Combine and conquer: advantages and disadvantages of fixed-dose combination therapyD S H Bell
Diabetes, Obesity & Metabolism|October 14, 2011
Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetesD S H Bell
Diabetes, Obesity & Metabolism|May 17, 2011
Why does quick-release bromocriptine decrease cardiac events?D S H Bell
Diabetes, Obesity & Metabolism|December 22, 2005
Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when added at an advanced stage of type 2 diabetesD S H Bell, F Ovalle
Diabetes, Obesity & Metabolism|August 4, 2004
Outcomes of initiation of therapy with once-daily combination of a thiazolidinedione and a biguanide at an early stage of type 2 diabetesD S H Bell, F Ovalle
Diabetes, Obesity & Metabolism|March 5, 2002
Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitusF Ovalle, D S H Bell
Diabetes, Obesity & Metabolism|October 1, 2009
Rediscovering bile acid sequestrantsD S H Bell, James H O'Keefe
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Diabetologia|January 20, 2007
Comment on: Distiller LA, Joffe BI (2006) From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a 'routine' diabetes clinic? Diabetologia 49:2793-2794D S H Bell
Diabetologia|June 30, 2010
Nocturnal hypoglycaemia presenting as somnambulismD S H Bell
Diabetologia|April 17, 2010
Hyperglycaemia and ketosis induced by gamma hydroxybutyrate (GHB)D S H Bell
Diabetes, Obesity & Metabolism|September 28, 2012
Combine and conquer: advantages and disadvantages of fixed-dose combination therapyD S H Bell
Diabetes, Obesity & Metabolism|October 14, 2011
Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetesD S H Bell
Diabetes, Obesity & Metabolism|May 17, 2011
Why does quick-release bromocriptine decrease cardiac events?D S H Bell
Diabetes, Obesity & Metabolism|December 22, 2005
Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when added at an advanced stage of type 2 diabetesD S H Bell, F Ovalle
Diabetes, Obesity & Metabolism|August 4, 2004
Outcomes of initiation of therapy with once-daily combination of a thiazolidinedione and a biguanide at an early stage of type 2 diabetesD S H Bell, F Ovalle
Diabetes, Obesity & Metabolism|March 5, 2002
Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitusF Ovalle, D S H Bell
Diabetes, Obesity & Metabolism|October 1, 2009
Rediscovering bile acid sequestrantsD S H Bell, James H O'Keefe
Pageof 2